Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus

Author(s): Ceylan-Isik AF, Fliethman RM, Wold LE, Ren J

Abstract

Cardiovascular diseases, the number one causes of death worldwide, are responsible for the majority of the increased morbidity and mortality seen in patients with diabetes mellitus. Useful therapies for diabetes include lifestyle modification and drugs to lower conventional cardiovascular risk factors, such as metformin, thiazolindinedione, sulfonylureas and evidence-based drugs. These hypoglycemic or antihyperglycemic agents are widely used either for monotherapy or in combination to improve glycemic control and to slow disease progression associated with a decline in pancreatic function in diabetic patients. In addition, a large body of clinical evidence has suggested that the appropriate use of traditional Chinese medicines with modern Western medicinal, or mainstream antidiabetic drugs, can prevent or ameliorate the development of diabetic complications. The traditional Chinese medicine diagnostics are based on "zheng" or "symptom", a system emphasizing the overall function of the human body. Since diabetes is a rather complicated metabolic disorder involving multi-organ damage, a majority of diabetic patients may be subject to multi-pharmacy to combat symptoms resulting from diabetes. Many diabetic patients choose alternative therapeutic approaches such as herbal or traditional Chinese medicine along with the mainstream anti-diabetic drugs, thus making alternative therapy for diabetes a popular remedy. In this review, we will briefly summarize the application of herbal or traditional Chinese medicinal therapy for diabetes with an emphasis on diabetic cardiovascular complications.

Similar Articles

Interactions between traditional Chinese medicines and Western therapeutics

Author(s): Chan E, Tan M, Xin J, Sudarsanam S, Johnson DE

The Role of Coenzyme Q10 in Heart Failure

Author(s): Weant KA, Smith KM

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure

Author(s): Sander S, Coleman CI, Patel AA, Kluger J, White CM

Studies on the constituents of Japanese and Chinese crude drugs

Author(s): Shibata S, Fujita M, Itokawa H, Tanaka O, Ishii T

Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng

Author(s): Chan RY, Chen WF, Dong A, Guo D, Wong MS

[Chemical studies of crude drugs (1)

Author(s): Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Taniyama T

Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells

Author(s): Fei XF, Wang BX, Tashiro S, Li TJ, Ma JS, et al.

Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells

Author(s): Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, et al.

Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models

Author(s): Xie X, Eberding A, Madera C, Fazli L, Jia W, et al.

Liquid chromatographic determination of less polar ginsenosides in processed ginseng

Author(s): Kwon SW, Han SB, Park IH, Kim JM, Park MK, et al.

[Determination of ginsenoside Rd and its metabolites in rat urine by LC-MS]

Author(s): Yang L, Xu SJ, Zeng X, Liu YM, Deng SG, et al.

Determination of Ginsenoside Rh2 in Enzyme Conversion by HPLC

Author(s): Jiang L, Zhao S, Ya L, Li J